Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on September 5, 2025
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2025 the Company granted inducement awards to …
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
Hilton, Guggenheim, Rockefeller ‘Legacy’ Families Rock Hamptons with Pink Floyd’s Scott Page at Global Passion Projects
EIN Presswire
·
September 5, 2025
A three-day convergence where legacy families, VCs and cultural icons sparked partnerships and purpose-driven innovation SOUTHAMPTON, NY, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- Global Passion Projects concluded its three-day “Succession …
Daram Showcases Enhanced Kaisar Men’s Healthcare Device at IFA 2025 – Second Consecutive Year of Global Presence
EIN Presswire
·
September 5, 2025
SEOUL, SEOUL, SOUTH KOREA, September 4, 2025 /EINPresswire.com/ -- Daram Co., Ltd., a South Korean healthcare technology innovator, is proud to announce its participation in IFA 2025, marking its third consecutive year at the world’s leading consumer …
Avania renforce son équipe de direction avec la nomination de quatre nouveaux dirigeants
GlobeNewswire
·
September 5, 2025
BILTHOVEN, Pays-Bas et BOSTON, 05 sept. 2025 (GLOBE NEWSWIRE) -- Avania, le leader mondial du conseil et du développement clinique dans le secteur de la MedTech, a le plaisir d’annoncer la nomination stratégique de quatre dirigeants éminents. Alors que le …
Avania verstärkt Führungsteam mit der Ernennung von vier neuen Führungskräften
GlobeNewswire
·
September 5, 2025
BILTHOVEN, Niederlande und BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Avania, der weltweit führende Partner für Medizintechnikberatung und klinische Entwicklung, freut sich, die Ernennung von vier angesehenen Führungskräften in strategische …
메드테크 자문기업인 Avania, 4명의 신규 임원 임명으로 리더십 팀 강화
GlobeNewswire
·
September 5, 2025
네덜란드 빌트호벤 및 보스턴, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 선도적인 메드테크(MedTech) 자문 서비스와 임상 개발 파트너인 Avania가 4명의 저명한 임원을 전략적 리더십 자리에 임명한다고 발표했다. 메드테크 산업이 점점 복잡해지는 규제 환경과 기술 혁신을 헤쳐 나가는 가운데, 이번에 선임된 신규 임원들은 임상 연구, 규제 업무, 운영, 정보기술, 사업 개발 분야에서 수십 년에 걸친 경험을 결합해 Avania의 …
BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting
GlobeNewswire
·
September 5, 2025
Company co-exhibiting with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three scientific posters feature BioStem’s proprietary allograft portfolio POMPANO BEACH, Fla., Sept. 05, 2025 (GLOBE …
Streamlined Cancer Tissue Analysis at KFSHRC Improves Patient Journey
GlobeNewswire
·
September 5, 2025
RIYADH, Saudi Arabia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre applies Large-Format Tissue Processing to support a smoother, more reassuring diagnostic experience for patients undergoing cancer surgery. The …
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
GlobeNewswire
·
September 5, 2025
MELBOURNE, Australia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced plans to commence a preclinical bioequivalence …
Healthinsurance.org: 5 ways to prepare now for Marketplace open enrollment
GlobeNewswire
·
September 5, 2025
Minneapolis, MN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- With Marketplace enrollees facing new documentation requirements and potentially large premium increases, now is the time to prepare for enrolling in 2026 coverage. According to healthinsurance.org, …
WellSpan announces changes to further enhance the safety and security of its facilities
GlobeNewswire
·
September 5, 2025
York, Pa., Sept. 05, 2025 (GLOBE NEWSWIRE) -- In support of its commitment to patient and team member safety, WellSpan Health today announced plans to further enhance security in its facilities, including increased weapons detection at entrances to its …
Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China
GlobeNewswire
·
September 5, 2025
SAN DIEGO and SUZHOU, China, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that ADG126 will be highlighted …
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer
GlobeNewswire
·
September 5, 2025
Poster details durability and efficacy of ateganosine (THIO) treatment in non-small cell lung cancer (NSCLC) CHICAGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage …
Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need
GlobeNewswire
·
September 5, 2025
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~ ~Subgroups - including Black or African American adults, older adults, women, and …
Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn’s Disease (FSCD)
GlobeNewswire
·
September 5, 2025
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Patient dosing expected to commence in H2 2025; Topline data anticipated in Q1 2026 Continued progress toward Phase 2 IND …
Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September
GlobeNewswire
·
September 5, 2025
FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Jarrod …
Mobile Mining Equipment Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029
EIN Presswire
·
September 5, 2025
The Business Research Company's Mobile Mining Equipment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 5, 2025 /EINPresswire.com/ -- What Is The Estimated Industry Size Of …